Abstract. It has been noted that hypothyroidism in pregnant women can adversely affect the children's subsequent psychoneurotic development. Also, transient elevation of serum free thyroxine is occasionally seen in the first trimester of normal pregnancy. However, normal thyroid function during pregnancy and the puerperal period has not been clearly defined in Japan. The aim of this study was to assess maternal thyroid function during pregnancy and puerperal period in Japan. The concentrations of thyroid stimulating hormone (TSH), free triiodo-thyronine (free T 3 ), free thyroxine (free T 4 ) and thyroid binding capacity (TBC) of 522 normal pregnant and puerperal women (119 in the first trimester; 132 in the second trimester; 135 in the third trimester and 136 in the early puerperium) were measured by electrochemiluminescence immunoassay. We compared the measured data with those of healthy nonpregnant control. Twenty-six (21.8%) of 119 women in the first trimester had lower TSH levels and 23 (16.9%) of 136 women in the early puerperium had higher TSH levels than the normal range of healthy nonpregnant controls. Free T 3 gradually decreased during pregnancy, although it remained within the normal control range. Eight (6.7%) of 119 women in the first trimester had high free T 4 levels, which gradually decreased during pregnancy. Sixty (44.4%) of 135 women in the third trimester had low free T 4 levels. The values of TBC in the second trimester increased compared with the first trimester and did not change in the third trimester and decreased after delivery. There were no correlations between maternal TSH and levels of thyroid hormones (free T 3 or free T 4 ), except for TSH and free T 4 in the first trimester. In conclusion, we showed that maternal thyroid function, especially TSH and free T 4 , changed during the course of pregnancy. In assessing the thyroid function associated with pregnancy, one needs to keep in mind the tendency toward low free T 4 levels in the third trimester and high TSH levels in the early puerperal period.
THYROID disorders are observed more frequently in women of childbearing age, and pregnancy is often complicated by these disorders. Hormonal changes and metabolic demands during pregnancy result in profound alterations in feto-maternal thyroid function. Glinoer et al. [1] studied the precise mechanism regulating the maternal thyroid function and concluded that thyroid changes in pregnancy were generally minor and consisted primarily of an increase in thyroid binding globulin (TBG). However, our understanding of thyroid function associated with pregnancy has evolved significantly over the past several years and Glinoer's review [2] reported that previous assumptions were far from the truth. New findings have yielded a new concept of gestational transient hyperthyroxinemia [3] [4] [5] [6] . A study by Haddow et al. [7] documented maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. Further studies highlighted the complex relations that exist between maternal thyroid deficiency during pregnancy and its possible consequences for the neuropsychointellectual development of the fetus and child [8, 9] . Undiagnosed subclinical hypothyroidism in pregnant women is probably more prevalent than usually considered. In this article, we examined data regarding changes in maternal thyroid function during pregnancy to assist in the systematic detection of thyroid abnormalities associated with pregnancy in Japan.
Patients and Methods

Patients
Five hundred and twenty-two pregnant women were enrolled at Koike Hospital. The study was limited to women with viable singleton pregnancies. The number of primigravida was 271 while multigravida was 251. Birth weight was 3073 ± 374 gram (mean ± standard deviation).
Methods
For cross-sectional analysis of thyroid function during pregnancy and puerperium, serum of thyroid stimulating hormone (TSH), free triiodo-thyronine (free T 3 ), free thyroxine (free T 4 ) and thyroid binding capacity (TBC) were measured in 522 normal pregnant and puerperal women. These 522 subjects consisted of 119 in the first trimester (less than 14 weeks of gestation), 132 in the second (14-27 weeks of gestation), 135 in the third trimester (more than 28 weeks of gestation) and 136 in the early puerperium (3-4 days after delivery). All hormone assays were measured by electrochemiluminescence immunoassay (ECLusys, Roche, Tokyo) [10] .
Statistical analyses of data were performed by nonrepeated measures ANOVA.
All research was conducted with informed consents of the patients.
Results
The biochemical parameters of thyroid function are given in Table 1 . Reference values are expressed as the mean values with the normal range of nonpregnant subjects in parentheses. TSH showed the lowest values in the first trimester and the highest values in the early puerperium. Free T 3 gradually decreased during pregnancy and increased in the early puerperium, although it remained within the normal control range. Free T 4 showed the highest values in the first trimester, gradually decreased during pregnancy and then increased in the early puerperium. TBC in the second trimester increased compared with the first trimester and did not change in the third trimester. After pregnancy, TBC decreased. Table 2 shows the total numbers and percentages of subjects with abnormal values compared with the normal range for nonpregnant subjects. In the first trimester, 26 (21.8%) of 119 subjects had abnormally low values of TSH. In the early puerperium, 23 (16.9%) of 136 subjects had abnormally high values of TSH. The values of free T 3 during pregnancy and puerperal period are within early the same range as in nonpregnant subjects. In the first trimester, 8 (6.7%) of 119 subjects had abnormally high values of free T 4 . In the second and third trimester, 28 (21.2%) of 132 subjects and 60 (44.4%) of 135 subjects had abnormally low values of free T 4 . In the early puerperium, 41 (30.1%) of 136 subjects indicated abnormally low values of free T 4 . In the first trimester, the values of TBC remained in the same range as for nonpregnant subjects. Afterward, TBC in most subjects rose and was maintained at high levels until term. After delivery, it decreased. Table 3 shows the normal range of thyroid function for pregnant and puerperal women based on our data. We investigated the correlation between TSH and thyroid hormones (Table 4 ). There is a negative correlation between TSH and freeT 4 (R = 0.527) only in the first trimester. We detected a weak negative correlation between TSH and free T 4 in the second and third trimesters, and found a weak negative correlation between TSH and free T 3 during pregnancy. No correlations between TSH and thyroid hormones were detected during early puerperium.
Discussion
Pregnancy is accompanied by alterations in thyroid function because of the rise in hCG and thyroglobulin. Glinoer et al. [1] indicated that free hormone concentrations decrease during pregnancy. However, free T 4 concentration remained within the reference range for nonpregnant subjects in most women. The negative feedback control system of hypothalamic-pituitarythyroid axis functions is normal in pregnant women, which means that serum thyrotropin concentrations during most pregnancies are similar to those in nonpregnant women [11] .
Women with hypothyroidism who become pregnant carry an increased risk for obstetrical complications such as intrauterine fetal death, gestational hypertension, placental abruption, and poor perinatal outcome [12] [13] [14] [15] . Until now we have diagnosed hypothyroidism during pregnancy by means of low levels of free T 3 and T 4 and high levels of TSH and positive thyroid antibodies, using the reference range established for nonpregnant subjects. Recently, it has become possible to measure thyroid related hormones by means of the highly sensitive electrochemiluminescence immunoassay [10] . While serum albumin during pregnancy shows lower levels than the normal range of healthy nonpregnant controls, this method is not so influenced by albumin or blocking antibody (human anti mouse antibodies, anti T 3 and T 4 antibody) [16] . Electrochemiluminescence immunoassay of free T 3 thus led to correct values according to the patients' thyroid status [17] . Therefore we should reinvestigate the normal range of thyroid related hormones and CBC during pregnancy and puerperal period by means of this measurement. In the second and especially in the third trimester, many subjects showed low values of free T 4 , even though they had normal TSH and free T 3 levels. Thus, we can evaluate maternal thyroid function in the second and third trimester by examining TSH and free T 3 . Maternal low T 4 concentration and an increase of TBC are thought to be physiologically normal in the second and third trimester during pregnancy. Therefore, the relationship between thyroid hormones and TSH during pregnancy differs from that in the nonpregnant period. Hormonal changes and metabolic demands during pregnancy results in profound alternations in the biochemical parameters of thyroid function. These results occurred due to high estrogen levels, human gonadotropin levels and modifications in the peripheral metabolism of thyroid hormones through transplacental passage and deiodination [8] .
The major cause of hyperthyroidism in women of childbearing age is Graves' disease. Accurate diagnosis of Graves' disease is important, because untreated hyperthyroidism is associated with fetal loss, premature labor and low birth weight [18] . It is recommended that TSH receptor antibody (TRAb) titers be assayed because high serum TRAb value during pregnancy is one of the risk factors for poor perinatal outcome [19, 20] . Gestational hyperthyroidism of nonautoimmune origin occurring in women with normal pregnancy has recently been established [6] . This type of gestational transient thyrotoxicosis (GTT) differs from Graves' disease as it occurs in women without a past history of Graves' disease and without detectable thyroid stimulating antibody (TSAb). In a review article [21] , it is reported that the prevalence of GTT may be as high as 2-3% of all pregnancies. In our study, some subjects, whether they had clinical symptoms or not, showed high values of free T 4 (6.7%) and low values of TSH (21.8%). It is not necessary to treat such patients for hyperthyroidism. A previous report [3] by means of other assay and our results are the same.
The clinical courses of autoimmune thyroid disorders associated with Graves' disease generally tend to improve during pregnancy, because there is a progressive decrease in the titers of autoimmune antibodies and an increase of hormone-binding capacity due to rise in TBG and estrogen. Hashimoto's disease also has the same clinical course because of the decrease in the titers of autoimmune antibodies. Due to large changes of antibodies and hormones, this latter disease may get worse after delivery, hence we must carefully monitor puerperal maternal thyroid function. However, our data indicated low free T 4 and high TSH levels in the early puerperal period and these findings suggested that the cause of the high initial TSH values was not autoimmune disease. The same argument was reported by Lao et al. and Sack et al. [22, 23] . Therefore, the early puerperal period is not an appropriate time to assess the postpartum maternal thyroid function.
In conclusion, further studies are needed to assess the specific aspects of thyroid function associated with pregnancy.
